Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection (Q37771941)

22 August 2017

1 reference

title

Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection (English)

1 reference

22 August 2017

1 reference

William K Decker

1

1 reference

22 August 2017

Amar Safdar

series ordinal

2

1 reference

22 August 2017

publication date

1 July 2010

1 reference

Expert Review of Vaccines

22 August 2017

published in

1 reference

22 August 2017

volume

9

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

721-730

1 reference

Evaluation of vaccine dosing in patients with solid tumors receiving myelosuppressive chemotherapy

22 August 2017

cites work

1 reference

Strategies for herpes zoster vaccination of immunocompromised patients

21 January 2018

1 reference

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

21 January 2018

1 reference

TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

21 January 2018

1 reference

The role of tregs in glioma-mediated immunosuppression: potential target for intervention.

21 January 2018

1 reference

TGF-beta: a master of all T cell trades

21 January 2018

1 reference

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets

21 January 2018

1 reference

Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10.

21 January 2018

1 reference

Dendritic cell dysfunction in cancer: a mechanism for immunosuppression

21 January 2018

1 reference

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

21 January 2018

1 reference

Tumor-induced modulation of dendritic cell function

21 January 2018

1 reference

Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue

21 January 2018

1 reference

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

21 January 2018

1 reference

Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines

21 January 2018

1 reference

Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells

21 January 2018

1 reference

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

21 January 2018

1 reference

Ceramide mediates tumor-induced dendritic cell apoptosis

21 January 2018

1 reference

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

21 January 2018

1 reference

Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen

21 January 2018

1 reference

Indoleamine 2,3-dioxygenase in immune suppression and cancer.

21 January 2018

1 reference

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

21 January 2018

1 reference

The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies

21 January 2018

1 reference

Soluble HLA-G: Are they clinically relevant?

21 January 2018

1 reference

The immunodeficiency of chronic lymphocytic leukaemia

21 January 2018

1 reference

Respiratory viral infections in immunocompetent and immunocompromised persons

21 January 2018

1 reference

Epidemiology of Influenza A virus infection in patients with acute or chronic leukemia

21 January 2018

1 reference

Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.

21 January 2018

1 reference

Respiratory virus infections in bone marrow transplant recipients: the European perspective

21 January 2018

1 reference

Respiratory virus infections in stem cell transplant patients: the European experience

21 January 2018

1 reference

Low mortality rates related to respiratory virus infections after bone marrow transplantation

21 January 2018

1 reference

Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy

21 January 2018

1 reference

Seroconversion after influenza vaccination in patients with lung cancer

21 January 2018

1 reference

Responses of patients with neoplastic diseases to influenza virus vaccine

21 January 2018

1 reference

Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae

21 January 2018

1 reference

Influenza immunisation in children with solid tumours

21 January 2018

1 reference

Response to influenza immunisation during treatment for cancer

21 January 2018

1 reference

Influenza immunization in immunosuppressed children

21 January 2018

1 reference

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma

21 January 2018

1 reference

Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity

21 January 2018

1 reference

21 January 2018

1 reference

Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.

21 January 2018

1 reference

Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma

21 January 2018

1 reference

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

21 January 2018

1 reference

Dendritic cell immunotherapy for the treatment of neoplastic disease

21 January 2018

1 reference

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

21 January 2018

1 reference

Immunotherapies in HIV-1 infection

21 January 2018

1 reference

Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells

21 January 2018

1 reference

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

21 January 2018

1 reference

De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination

21 January 2018

1 reference

Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood

21 January 2018

1 reference

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes

21 January 2018

1 reference

Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA

21 January 2018

1 reference

Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells

21 January 2018

1 reference

Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo

21 January 2018

1 reference

Antigen-specific immune responses to influenza vaccine in utero.

21 January 2018

1 reference

Fewer CTL, not enhanced NK cells, are sufficient for viral clearance from the lungs of immunocompromised mice

21 January 2018

1 reference

Human interleukin-12 enhances interferon-gamma-producing influenza-specific memory CD8+ cytotoxic T lymphocytes.

21 January 2018

1 reference

Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.

21 January 2018

1 reference

Deficient T(H)-1 responses from TNF-alpha-matured and alpha-CD40-matured dendritic cells.

21 January 2018

1 reference

Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens

21 January 2018

1 reference

Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.

21 January 2018

1 reference

B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia

21 January 2018

1 reference

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

21 January 2018

1 reference

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.10.68

1 reference

22 August 2017

1 reference